These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4999859)

  • 1. [Biological properties of 1,2-benzisothiazole compounds. Hypoglycemic activity of some benzisothiazolylacylamidoethylbenzensulfonylureas].
    Amoretti L; Agosti A; Catellani PL
    Boll Soc Ital Biol Sper; 1971 May; 47(10):299-302. PubMed ID: 4999859
    [No Abstract]   [Full Text] [Related]  

  • 2. [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea].
    Beyer J; Cordes U; Sell G; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2176. PubMed ID: 4198965
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypoglycemic activity and tolerance of glibenclamide-phenformin association].
    Fanelli O; Bianchi G; Fascetti P; Trallori L
    Boll Chim Farm; 1971 Aug; 110(8):470-8. PubMed ID: 5002955
    [No Abstract]   [Full Text] [Related]  

  • 4. [Glibornuride, a new high-effective antidiabetic agent. Pharmacological and biochemical comparative studies in various animal species and animal experimental models].
    Lorch E; Gey KF; Sommer P
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2154. PubMed ID: 4198964
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia.
    Szoke E; Gosmanov NR; Sinkin JC; Nihalani A; Fender AB; Cryer PE; Meyer C; Gerich JE
    Metabolism; 2006 Jan; 55(1):78-83. PubMed ID: 16324923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacological aspects of comparative studies on different blood sugar-lowering sulfonylureas].
    Beyer J; Haupt E; Cordes U; Sell G; Schöffling K
    Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1668-75. PubMed ID: 4205544
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in blood glucose and insulin in 4 normal subjects after administration of a single dose of glipizide and glibenclamide].
    Rizzi G; Isaia GC
    Minerva Med; 1974 Jan; 65(1):58-9. PubMed ID: 4214132
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in plasma amino acids levels and "in vivo" gluconeogenesis from alanine in rats chronically treated with sulfonylureas.
    Alemany M; Palou A; Codina J; Herrera E
    Diabete Metab; 1978 Sep; 4(3):181-6. PubMed ID: 101403
    [No Abstract]   [Full Text] [Related]  

  • 9. Insulinotropic action of a new sulfonylurea: gliclazide.
    Malaisse WJ; Leclercq-Meyer V
    Rev Eur Etud Clin Biol; 1972 Mar; 17(3):310-4. PubMed ID: 4626523
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental studies on the mechanism of thrombocyte aggregation inhibition caused by sulfonylurea compounds. 2. Modification of blood sugar and thrombocyte aggregation by oral antidiabetics].
    Losert W; Hoder A; Scholz C
    Arzneimittelforschung; 1975 Feb; 25(2):170-9. PubMed ID: 804311
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of hypoglycemic sulfonylurea preparations on the heart conduction system].
    Pogátsa G; Németh M
    Orv Hetil; 1980 Sep; 121(37):2255-7. PubMed ID: 6780962
    [No Abstract]   [Full Text] [Related]  

  • 12. Glipizide: experimental study and comparison with other sulfonylureas.
    Loubatieres-Mariani MM
    Acta Endocrinol Suppl (Copenh); 1980; 239():26-32. PubMed ID: 6776761
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment.
    Harrigan RA; Nathan MS; Beattie P
    Ann Emerg Med; 2001 Jul; 38(1):68-78. PubMed ID: 11423816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The toxicology of glisoxepide, a new oral antidiabetic. Results of animal studies].
    Tettenborn D
    Arzneimittelforschung; 1974 Mar; 24(0):409-18. PubMed ID: 4408138
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of oral antidiabetics on the biosynthesis of proinsulin in the rat].
    Tjioe TO; Wacker A
    Arzneimittelforschung; 1972 Nov; 22(11):1890-2. PubMed ID: 4633587
    [No Abstract]   [Full Text] [Related]  

  • 16. [Derivatives of 2-mercaptobenzenesulphonylamide. IV. Synthesis and properties of some hypoglycemic agents derived from N-(4-chloro-2-mercapto-5-methylbenzenesulphonyl)urea].
    Brzozowski Z; Wójcikowski C
    Acta Pol Pharm; 1990; 47(3-4):45-8. PubMed ID: 12959242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-acting sulfonylureas -- long-acting hypoglycaemia.
    Veitch PC; Clifton-Bligh RJ
    Med J Aust; 2004 Jan; 180(2):84-5. PubMed ID: 14723592
    [No Abstract]   [Full Text] [Related]  

  • 18. [Retrolective study design -- a new tool of evidence-based medicine].
    Martin S
    Dtsch Med Wochenschr; 2005 Jul; 130 Suppl 2():S86-90. PubMed ID: 15988675
    [No Abstract]   [Full Text] [Related]  

  • 19. [Thyroid gland function of patients with diabetes in long-term use of glibornuride].
    Reinwein D
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2221. PubMed ID: 4125093
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sulfonylurea-induced hypoglycemia. An iatrogenic and potentially fatal condition].
    Carlsen SM
    Tidsskr Nor Laegeforen; 1997 Sep; 117(21):3079-82. PubMed ID: 9381441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.